Why 3D Systems Didn't Skyrocket After Earnings
Oct 29th 2013 5:01PM
Updated Oct 29th 2013 5:02PM
The stock market seemed to have mixed reactions about 3D Systems after the company reported earnings on Tuesday morning. The primary culprit behind the whipsaw trading was the company's decreased guidance, which initially sent shares lower, but once investors digested the rest of the company's results, it lead to share gains. Investors should try to ignore the daily musings of the market and instead focus on the company's fundamentals.
This quarterly report included several exciting details about how 3D Systems' long-term plans are continuing to progress. The recent Phenix Systems acquisition looks to be a great boost for the company, and investors were treated to tremendous results from the Cube line of printers for the first time.
In the video below, Motley Fool Analyst Blake Bos digs into 3D System's results, pulls the most important information out for investors, and offers several areas to watch in the future.
1 company growing faster than 3-D printing companies
This incredible tech stock is growing twice as fast as Google and Facebook, and more than three times as fast as Amazon.com and Apple. Watch our jaw-dropping investor alert video today to find out why The Motley Fool's chief technology officer is putting $117,238 of his own money on the table, and why he's so confident this will be a huge winner in 2013 and beyond. Just click here to watch!
The article Why 3D Systems Didn't Skyrocket After Earnings originally appeared on Fool.com.Blake Bos has no position in any stocks mentioned. The Motley Fool recommends 3D Systems. The Motley Fool owns shares of 3D Systems and has the following options: short January 2014 $36 calls on 3D Systems and short January 2014 $20 puts on 3D Systems. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.